Predictive Factors for Early Relapse in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplant.

Introduction: Despite advances in therapy for multiple myeloma, patients have continued to experience relapse. We sought to better understand this.

Objective: To identify factors that predict early relapse in patients with multiple myeloma who receive autologous hematopoietic peripheral stem cell transplant (HSCT).